tirzepatide journal club Essential Tracker | Journey Begins: The Ultimate Companion for the First Six Months of Your Weight Loss Journey Tirzepatide vs Dulaglutide for Cardiovascular

Revised guidelines ASA guidelines released at the end of June 2023 now advise physicians and patients to hold GLP-1 agonists on the day of the procedure for patients who take medication daily and a week for patients who take the medication weekly

They can help with significant weight loss and they've shown some benefits in cardiovascular outcomes

Andrews' Diseases of the Skin: Clinical Dermatology

The FDA issued a warning about chelation therapies and other calcium disodium uses that are not approved by the FDA

GLP-1 drugs may increase the risk of developing serious health conditions such as thyroid cancer and pancreatic cancer

Enhanced Motivation and Accountability Being part of a structured program provides many things, including motivation and accountability